Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jubilant IngreviaBOM:543271 -2.31%79 Days Payable is 138.72 as of Mar. 2026, which is 5% above its 10-year median of 132.07. GuruFocus rates BOM:543271 with a GF Score™ of 79/100 and a GF Value™ of ₹704.91 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,554 Chemicals companies, Jubilant Ingrevia ranks better than 86.1% on this metric.
The historical rank and industry rank for Jubilant Ingrevia's Days Payable or its related term are showing as below:
BOM:543271'
s Days Payable Range Over the Past 10 Years
Min: 92.03 Med: 132.07 Max: 315.65
Current: 136.24
During the past 7 years, Jubilant Ingrevia's highest Days Payable was 315.65. The lowest was 92.03. And the median was 132.07.
BOM:543271's Days Payable is ranked better than 86.1% of 1554
companies
in the Chemicals industry
Industry Median: 59.875
vs BOM:543271: 136.24
Jubilant Ingrevia's Days Payable
declined
from Mar. 2025 (139.53) to Mar. 2026 (138.72).
It may suggest that Jubilant Ingreviaaccelerated paying its suppliers.
Jubilant Ingrevia Days Payable Related Terms
Jubilant Ingrevia Days Payable Historical Data
* Premium members only.
The historical data trend for Jubilant Ingrevia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543271 vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Jubilant Ingrevia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jubilant Ingrevia Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's Days Payable distribution charts can be found below:
* The bar in red indicates where Jubilant Ingrevia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Jubilant Ingrevia's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Ingrevia (BOM:543271) has a Days Payable of 138.72 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jubilant Ingrevia and its competitors. This is near median its historical median of 132.07. Over the past decade, Jubilant Ingrevia's Days Payable has ranged from 92.03 to 315.65. According to the industry distribution chart, Jubilant Ingrevia ranks #216 out of 1554 companies in the Chemicals industry, placing it in the top 13.9%.
Is Jubilant Ingrevia's Days Payable too high?
Jubilant Ingrevia's current Days Payable of 138.72 is near median its 10-year median of 132.07. Over the past 10 years, this metric has ranged from a low of 92.03 to a high of 315.65. The Chemicals industry median Days Payable is 59.88. Jubilant Ingrevia's value of 138.72 is 131.7% above this industry median. Based on the distribution chart, Jubilant Ingrevia ranks #216 out of 1554 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Jubilant Ingrevia has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Jubilant Ingrevia ranks #216 out of 1554 companies for Days Payable. This places Jubilant Ingrevia in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 59.88. Jubilant Ingrevia's value of 138.72 is 131.7% above this benchmark. Historically, Jubilant Ingrevia's own Days Payable has ranged from 92.03 to 315.65 over the past decade. While the company's 10-year median is 132.07 vs. the industry median of 59.88, Jubilant Ingrevia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.88, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jubilant Ingrevia's current Days Payable of 138.72 is 131.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jubilant Ingrevia and its competitors. For the Chemicals industry, the median Days Payable is 59.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jubilant Ingrevia's current Days Payable is 138.72, which is near median its own 10-year median of 132.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Fairly Valued. The stock's GF Value™ is ₹704.91, compared to a current price of ₹740.10 — trading 5% above its estimated fair value. The current Days Payable is 138.72, which is near median its 10-year median of 132.07 and 131.7% above the Chemicals industry median of 59.88. Jubilant Ingrevia's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current Days Payable is 138.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?
Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be overvalued.
The current stock price of ₹740.10 is trading 5% above its estimated GF Value™ of ₹704.91.
GuruFocus considers Jubilant Ingrevia to be Fairly Valued.
Key valuation signals for BOM:543271:
Days Payable: 138.72 (near median its 10-year median of 132.07)
GF Value™: ₹704.91 vs. price of ₹740.10 (5% above fair value)
Industry Position: 131.7% above the Chemicals median (#216 of 1554)
No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
79GF Score
Get the complete analysis for BOM:543271
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543271 has been successfully added to your 
